Weight gain whilst taking Victoza (liraglutide) is uncommon and often puzzling, as this GLP-1 receptor agonist is typically associated with weight reduction in people with type 2 diabetes. If you are gaining weight on Victoza, the cause is usually unrelated to the medication itself. Factors such as improved glycaemic control, dietary changes, concurrent medications, fluid retention, or underlying medical conditions may be responsible. Understanding why this paradoxical response occurs is essential for effective diabetes management and achieving your health goals. This article explores the mechanisms behind Victoza's usual weight effects, identifies potential causes of unexpected weight gain, and provides practical guidance on what to do if you experience this issue.
Quick Answer: Weight gain on Victoza is uncommon and typically caused by factors other than the medication itself, such as improved glycaemic control, dietary changes, concurrent medications, fluid retention, or underlying medical conditions.
Victoza (liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus. The medication works by mimicking the action of naturally occurring GLP-1, a hormone that regulates blood glucose levels and appetite. When administered as a once-daily subcutaneous injection, Victoza stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon release, and slows gastric emptying.
One of the well-documented effects of Victoza is its association with weight reduction rather than weight gain. Clinical trials have shown that patients treated with liraglutide typically experience modest weight loss, though the magnitude varies depending on background therapy and individual factors. According to the Victoza Summary of Product Characteristics (SmPC), weight reduction is generally observed during the first 3-6 months of treatment. It's important to note that Victoza (liraglutide 1.2-1.8 mg daily) is licensed for diabetes management, not weight loss—unlike Saxenda (liraglutide 3 mg daily), which is specifically licensed for weight management.
The weight-reducing effect occurs through multiple mechanisms: the medication enhances satiety signals in the brain, reduces appetite, and delays stomach emptying, which collectively lead to decreased caloric intake. NICE guidance (NG28) recommends GLP-1 receptor agonists like Victoza under specific circumstances, including when certain BMI thresholds are met and other treatments haven't achieved glycaemic targets.
The weight loss associated with Victoza generally occurs gradually and tends to plateau over time. Most patients notice reduced hunger and earlier feelings of fullness during meals. Weight gain while taking Victoza is uncommon and often reflects other factors beyond the medication itself.
Mounjaro® is the most innovative GLP-1 medication proven to dramatically curb appetite, hunger, and cravings to help professional men achieve substantial weight loss.
Start Here
Wegovy® is a weekly injectable GLP-1 medication with proven effectiveness in reducing appetite, hunger, and cravings to help busy professionals lose significant weight.
Start HereWeight gain whilst taking Victoza is uncommon and typically not directly caused by the medication itself. However, several factors may explain this paradoxical response. Firstly, improved glycaemic control can sometimes lead to weight gain in diabetes management. When blood glucose levels are poorly controlled, excess glucose is lost through urine (glycosuria), representing wasted calories. As Victoza improves glucose control, this caloric loss stops, and some patients may experience weight stabilisation or modest gain if dietary habits remain unchanged.
Dietary compensation represents another important consideration. Some patients, feeling better with improved glucose control or experiencing reduced hypoglycaemia risk, may unconsciously increase their food intake. Additionally, if patients believe the medication will automatically cause weight loss, they might relax dietary vigilance or portion control. Some patients may also experience a reduction in the initial appetite-suppressing effects over time, particularly the slowing of gastric emptying, which can adapt with continued treatment.
Concurrent medications may also contribute to weight gain. Many patients with type 2 diabetes take multiple medications, and some commonly prescribed drugs promote weight gain. According to the British National Formulary (BNF), these include certain antidepressants (particularly mirtazapine and some SSRIs), antipsychotics, corticosteroids, beta-blockers, and some anticonvulsants. If any of these medications were started around the same time as Victoza or had dosage adjustments, they might be the actual cause of weight gain.
Patients taking Victoza alongside insulin or sulphonylureas may experience hypoglycaemia, potentially leading to increased snacking or compensatory eating. Similarly, starting or stopping other diabetes medications, such as SGLT2 inhibitors (which typically cause weight loss), can affect weight trajectory.
Fluid retention can masquerade as weight gain. While oedema is not commonly associated with Victoza according to its SmPC, other diabetes medications (particularly thiazolidinediones like pioglitazone) or cardiovascular drugs may cause fluid accumulation. This presents as increased weight on the scales but represents water retention rather than fat gain, often accompanied by swollen ankles or legs.
Several underlying medical conditions can cause weight gain that coincidentally occurs during Victoza treatment but is unrelated to the medication itself. Hypothyroidism (underactive thyroid) is a common endocrine disorder that frequently coexists with type 2 diabetes. Thyroid hormone deficiency slows metabolism, leading to weight gain, fatigue, cold intolerance, and constipation. The condition develops gradually, and symptoms may be attributed to diabetes or ageing. Thyroid function tests (TSH, free T4) can readily diagnose this condition, and thyroid hormone replacement typically reverses the weight gain.
Polycystic ovary syndrome (PCOS) affects many women of reproductive age and commonly coexists with insulin resistance and type 2 diabetes. PCOS causes hormonal imbalances that promote weight gain, particularly around the abdomen, alongside irregular periods, excess hair growth, and acne. Women with PCOS often find weight management particularly challenging, and the condition may worsen despite diabetes treatment.
Cushing's syndrome, though rare, results from excessive cortisol production and causes characteristic central weight gain, facial rounding, and purple striae. This condition requires specialist endocrine investigation. Similarly, insulinoma (insulin-secreting tumour) is extremely rare but causes inappropriate insulin secretion, leading to hypoglycaemia and compensatory eating. More commonly, hypoglycaemia is caused by insulin or sulphonylurea therapy, which should be reviewed first if low blood glucose occurs.
Heart failure and kidney disease can cause fluid retention presenting as weight gain. Both conditions are more prevalent in people with diabetes and may develop or worsen over time. Heart failure typically presents with breathlessness, ankle swelling, and reduced exercise tolerance. Seek urgent medical attention if you experience rapid weight gain (>2kg over a few days) with shortness of breath, especially when lying flat, or worsening ankle swelling. Kidney disease may be asymptomatic until advanced stages but is routinely monitored in diabetes care.
Depression and other mental health conditions can also contribute to weight gain through reduced activity levels, comfort eating, or medication side effects, and these conditions are more common in people living with chronic diseases like diabetes. Other factors to consider include pregnancy (which should be discussed with your healthcare team as Victoza is not recommended during pregnancy) and recent smoking cessation.
If you are experiencing unexpected weight gain whilst taking Victoza, several practical steps can help identify the cause and address the issue. Contact your GP or diabetes specialist nurse to discuss your concerns. They can review your complete medication list, assess for potential drug interactions or side effects from other medicines, and arrange appropriate investigations. Do not stop taking Victoza without medical advice, as this may worsen your diabetes control.
Seek urgent same-day medical attention if you experience rapid weight gain (more than 2kg in a few days) accompanied by breathlessness, chest pain, difficulty breathing when lying flat, or marked swelling of the ankles, legs or abdomen, as these may indicate heart failure or serious kidney problems.
Your healthcare team will likely recommend blood tests to exclude underlying conditions. These typically include thyroid function tests, renal function, liver function, and potentially cortisol levels if clinically indicated. They may also review your HbA1c to assess overall glucose control and check for any deterioration that might explain the weight change. If you are a woman of childbearing age, a pregnancy test may be appropriate, as Victoza is not recommended during pregnancy.
Keep a detailed food and symptom diary for at least one week before your appointment. Record everything you eat and drink, portion sizes, timing of meals, and any symptoms such as increased hunger, thirst, or urination. This information helps identify dietary patterns that might contribute to weight gain and provides valuable clinical information. Similarly, monitor your weight consistently—weigh yourself at the same time of day, using the same scales, and wearing similar clothing to ensure accuracy.
Review your lifestyle factors honestly. Consider whether your physical activity levels have decreased, perhaps due to other health issues, joint problems, or life circumstances. Assess your sleep quality, as poor sleep is associated with weight gain and worsened glucose control. Evaluate stress levels, as chronic stress may promote weight gain and comfort eating.
If investigations reveal no underlying medical cause, your diabetes team may suggest adjusting your treatment regimen. This might involve optimising the Victoza dose (if not already at the maximum 1.8mg daily), reviewing other diabetes medications (particularly insulin or sulphonylureas if hypoglycaemia is occurring), or providing referral to a dietitian for personalised nutritional advice. Some patients benefit from structured weight management programmes or psychological support to address eating behaviours.
If you suspect your weight gain might be a side effect of Victoza, you can report this through the MHRA Yellow Card scheme, which monitors medication safety. Remember that weight management in diabetes is multifactorial, and a comprehensive approach addressing diet, activity, medications, and any underlying conditions offers the best chance of success.
No, weight gain is uncommon with Victoza. Clinical trials show that liraglutide typically causes modest weight reduction through appetite suppression and delayed gastric emptying, with weight loss generally observed during the first 3–6 months of treatment.
Yes, concurrent medications such as insulin, sulphonylureas, certain antidepressants, antipsychotics, corticosteroids, and beta-blockers can promote weight gain. Your healthcare team should review your complete medication list to identify potential contributors.
Seek urgent same-day medical attention if you experience rapid weight gain (more than 2kg in a few days) with breathlessness, chest pain, difficulty breathing when lying flat, or marked swelling of the ankles, legs, or abdomen, as these may indicate heart failure or serious kidney problems.
All medical content on this blog is created based on reputable, evidence-based sources and reviewed regularly for accuracy and relevance. While we strive to keep content up to date with the latest research and clinical guidelines, it is intended for general informational purposes only.
DisclaimerThis content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional with any medical questions or concerns. Use of the information is at your own risk, and we are not responsible for any consequences resulting from its use.
